What do people think is the likely outcome of the audit review. Sales down, revenue down, costs similar and cash position very precarious is my bet. Discretionary spending will low in this current global climate, and there seem to be no new products with potential mass appeal on the horizon. Perhaps a surprise or two at NAB, but the company has not hinted of anything.
- Forums
- ASX - By Stock
- Ann: AMS Audit Review Status
What do people think is the likely outcome of the audit review....
Featured News
Add AMS (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.0¢ |
Change
-0.003(13.0%) |
Mkt cap ! $24.30M |
Open | High | Low | Value | Volume |
2.3¢ | 2.3¢ | 2.0¢ | $57.55K | 2.733M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 2119999 | 2.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 745198 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 2119999 | 0.020 |
3 | 1083031 | 0.019 |
1 | 50000 | 0.018 |
2 | 80000 | 0.017 |
3 | 245000 | 0.016 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 387001 | 2 |
0.024 | 6652 | 1 |
0.026 | 126993 | 4 |
0.027 | 50000 | 1 |
0.028 | 107000 | 2 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
AMS (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online